STAT - Reporting from the frontiers of health and medicine

In the Lab

Adam's Take

First Opinion

By Parsa Erfani, Caroline Lee, and Nishant Uppal

Politics Quinn Nystrom is betting a platform laser-focused on high insulin prices will propel her to Congress
First Opinion Colleges need to look beyond stopping parties to safely reopen in spring 2021
Biotech Bayer to buy gene therapy company AskBio for as much as $4 billion
Don't Miss As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies
Health WHO warns giving up on efforts to control Covid-19 would be ‘dangerous’

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Health Canada releases final version of controversial regulations for controlling drug prices
Foghorn Therapeutics raises $120 million in IPO
Pharmalittle: A Covid-19 vaccine induced immune response in older people; Covid-19 insiders sold lots of stock

A STAT Investigation

Special Report

Health

By Gabrielle Glaser

Health

By Amy Sokolow

Heavyweights

Politics

In the Lab At the top of her field, a Covid-19 researcher fights back against a different kind of virus: sexism and power imbalances in science
Health The Covid-19 Tracker
First Opinion I have all the symptoms of a Covid-19 long-hauler — but I’m hesitant to identify myself as one
Special Report The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond
Health WHO warns giving up on efforts to control Covid-19 would be ‘dangerous’
Health Watch: mRNA vaccines face their first test in the fight against Covid-19. How do they work?
Health Amid pandemic, U.S. has seen 300,000 ‘excess deaths,’ with highest rates among people of color
Health Covid-19 vaccine trials from AstraZeneca, Johnson & Johnson to restart